Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Corticosteroid-resistant immune-related adverse events: a systematic review
Eveline Daetwyler, Till Wallrabenstein, David König, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 1, pp. e007409-e007409
Open Access | Times Cited: 10

Showing 10 citing articles:

PD-1/PD-L1 Inhibitor - Related Adverse Events and Their Management in Breast Cancer
Chuqi Lei, Xiangyi Kong, Yuan Li, et al.
Journal of Cancer (2024) Vol. 15, Iss. 9, pp. 2770-2787
Open Access | Times Cited: 5
Risk Factors for Immune Checkpoint Inhibitor-Induced Liver Injury and the Significance of Liver Biopsy
Miki Kawano, Yoshihiko Yano, Atsushi Yamamoto, et al.
Diagnostics (2024) Vol. 14, Iss. 8, pp. 815-815
Open Access | Times Cited: 5
Immune-Related Adverse Events Induced by Immune Checkpoint Inhibitors and CAR-T Cell Therapy: A Comprehensive Imaging-Based Review
Chiara Pozzessere, Bianca Mazini, Patrick Omoumi, et al.
Cancers (2024) Vol. 16, Iss. 14, pp. 2585-2585
Open Access | Times Cited: 5
Engineering a Novel T‐Cell Epitope‐Based Vaccine Targeting PRAME in Cancer Immunotherapy
Zeynab Bayat, Zahra Majidi, Amir Taherkhani, et al.
Peptide Science (2025) Vol. 117, Iss. 1
Closed Access
Navigating the waters of immune checkpoint inhibitor pulmonary toxicity
R. Puthumana, S. Vehar, Abigail L. Koch
Journal of Precision Respiratory Medicine (2025) Vol. 8, Iss. 1, pp. 19-25
Open Access
Acknowledging and addressing real-world challenges to treating immune-related adverse events
Mitchell S. von Itzstein, David E. Gerber, Bonnie L. Bermas, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 7, pp. e009540-e009540
Open Access | Times Cited: 1
Immune-mediated liver injury from checkpoint inhibitors: mechanisms, clinical characteristics and management
Evangelos Triantafyllou, Cathrin Gudd, Lucia Possamai
Nature Reviews Gastroenterology & Hepatology (2024)
Closed Access | Times Cited: 1
Infliximab for Immune Checkpoint Inhibitor Therapy-Related Toxicities
CADTH
Canadian Journal of Health Technologies (2024) Vol. 4, Iss. 6
Open Access
Therapeutic agents for steroid-refractory immune checkpoint inhibitor-related myocarditis: a narrative review
Yang Wang, Shouchao Li, He Shi, et al.
Cardiovascular Diagnosis and Therapy (2024) Vol. 14, Iss. 4, pp. 679-697
Open Access
Hepatotoxicity in Cancer Immunotherapy: Diagnosis, Management, and Future Perspectives
Alberto Savino, A. Rossi, S. Fagiuoli, et al.
Cancers (2024) Vol. 17, Iss. 1, pp. 76-76
Open Access
Page 1

Scroll to top